Pär Gellerfors
VC Fund
Stockholm, Sweden
Pär Gellerfors is a VC fund in Stockholm focused on Biotechnology and Medical Device. Pär Gellerfors
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Pär Gellerfors invests in
Stages Pär Gellerfors invests in
Countries Pär Gellerfors invests in
Investment Focus
Industry
- Biotechnology 1 (100%)
- Medical Device 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Sigrid Therapeutics
|
Sigrid Therapeutics is developing an ingested medical device for lowering blood sugar in prediabetics. | $1.6M / Sep 05, 2019 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Pär Gellerfors invest in?
Pär Gellerfors invests primarily in Biotechnology and Medical Device startups, most often at Funding Round stage. Most of the 1 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Pär Gellerfors last invest?
The most recent investment recorded for Pär Gellerfors closed in Sep 2019. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
